These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9764786)

  • 1. Mycobacterium xenopi in HIV-infected patients: an emerging pathogen.
    Juffermans NP; Verbon A; Danner SA; Kuijper EJ; Speelman P
    AIDS; 1998 Sep; 12(13):1661-6. PubMed ID: 9764786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increasing incidence of Mycobacterium xenopi at Bellevue hospital: An emerging pathogen or a product of improved laboratory methods?
    Donnabella V; Salazar-Schicchi J; Bonk S; Hanna B; Rom WN
    Chest; 2000 Nov; 118(5):1365-70. PubMed ID: 11083687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mycobacterium xenopi clinical relevance and determinants, the Netherlands.
    van Ingen J; Boeree MJ; de Lange WC; Hoefsloot W; Bendien SA; Magis-Escurra C; Dekhuijzen R; van Soolingen D
    Emerg Infect Dis; 2008 Mar; 14(3):385-9. PubMed ID: 18325251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycobacterium xenopi infection in patients with human immunodeficiency virus infection.
    el-Helou P; Rachlis A; Fong I; Walmsley S; Phillips A; Salit I; Simor AE
    Clin Infect Dis; 1997 Aug; 25(2):206-10. PubMed ID: 9332511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycobacterium xenopi, Mycobacterium fortuitum, Mycobacterium kansasii, and other nontuberculous mycobacteria in an area of endemicity for AIDS.
    Shafer RW; Sierra MF
    Clin Infect Dis; 1992 Jul; 15(1):161-2. PubMed ID: 1617056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First randomised trial of treatments for pulmonary disease caused by M avium intracellulare, M malmoense, and M xenopi in HIV negative patients: rifampicin, ethambutol and isoniazid versus rifampicin and ethambutol.
    Research Committee of the British Thoracic Society
    Thorax; 2001 Mar; 56(3):167-72. PubMed ID: 11182006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A decade surveillance study of Mycobacterium xenopi disease and antimicrobial susceptibility levels in a reference teaching hospital of northern Italy: HIV-associated versus non-HIV-associated infection.
    Manfredi R; Nanetti A; Morelli S; Ferri M; Valentini R; Calza L; Chiodo F
    HIV Clin Trials; 2004; 5(4):206-15. PubMed ID: 15472795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiographic findings in patients with acquired immunodeficiency syndrome, pulmonary infection, and microbiologic evidence of Mycobacterium xenopi.
    Bankier AA; Stauffer F; Fleischmann D; Kreuzer S; Strasser G; Mossbacher U; Mallek R
    J Thorac Imaging; 1998 Oct; 13(4):282-8. PubMed ID: 9799136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycobacterium xenopi: innocent bystander or emerging pathogen?
    Jiva TM; Jacoby HM; Weymouth LA; Kaminski DA; Portmore AC
    Clin Infect Dis; 1997 Feb; 24(2):226-32. PubMed ID: 9114152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-tuberculous mycobacterial infections at San Francisco General Hospital.
    Sheu LC; Tran TM; Jarlsberg LG; Marras TK; Daley CL; Nahid P
    Clin Respir J; 2015 Oct; 9(4):436-42. PubMed ID: 24799125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary Mycobacterium xenopi infection in non-HIV-infected patients: a systematic review.
    Varadi RG; Marras TK
    Int J Tuberc Lung Dis; 2009 Oct; 13(10):1210-8. PubMed ID: 19793424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human immunodeficiency virus type 1-related pulmonary Mycobacterium xenopi infection: a need to treat?
    Kerbiriou L; Ustianowski A; Johnson MA; Gillespie SH; Miller RF; Lipman MC
    Clin Infect Dis; 2003 Nov; 37(9):1250-4. PubMed ID: 14557971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors which influence treatment initiation for pulmonary non-tuberculous mycobacterium infection in HIV negative patients; a multicentre observational study.
    Rawson TM; Abbara A; Kranzer K; Ritchie A; Milburn J; Brown T; Adeboyeku D; Buckley J; Davidson RN; Berry M; Kon OM; John L
    Respir Med; 2016 Nov; 120():101-108. PubMed ID: 27817806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spondylitis due to Mycobacterium xenopi in a human immunodeficiency virus type 1-infected patient: case report and review of the literature.
    Meybeck A; Fortin C; Abgrall S; Adle-Biassette H; Hayem G; Ruimy R; Yeni P
    J Clin Microbiol; 2005 Mar; 43(3):1465-6. PubMed ID: 15750135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycobacterium xenopi pulmonary disease - epidemiology and clinical features in non-immunocompromised patients.
    Marusić A; Katalinić-Janković V; Popović-Grle S; Janković M; Mazuranić I; Puljić I; Sertić Milić H
    J Infect; 2009 Feb; 58(2):108-12. PubMed ID: 19195711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycobacterium xenopi pulmonary infection resulting in self-limited immune reconstitution inflammatory syndrome in an HIV-1 infected patient.
    Leone S; Giglio S; Maio P; Capasso P; dell'Aquila G; Magliocca M; Nigro FS; Pacifico P; Acone N
    New Microbiol; 2009 Oct; 32(4):415-7. PubMed ID: 20128450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pulmonary infections with Mycobacterium xenopi in patients without HIV infection].
    Dixmier A; Meynard JL; Lalande V; Lebeau B; Chouaïd C
    Rev Mal Respir; 2007 Mar; 24(3 Pt 1):299-304. PubMed ID: 17417167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Miliary pulmonary nodules due to Mycobacterium xenopi in a steroid-induced immunocompromised patient successfully treated with chemotherapy: a case report.
    Okano Y; Shinohara T; Imanishi S; Takahashi N; Naito N; Taoka T; Kadota N; Ogushi F
    BMC Pulm Med; 2016 Jun; 16(1):92. PubMed ID: 27287608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Four cases of Mycobacterium xenopi pulmonary disease].
    Minami S; Suzuki K; Tsuyuguchi K; Sakatani M
    Kekkaku; 2004 Apr; 79(4):313-20. PubMed ID: 15168439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical and epidemiological study of disease caused by Mycobacterium kansasii in the metropolitan area of Bilbao, Spain].
    Leal Arranz MV; Gaafar A; Unzaga Barañano MJ; Crespo Notario JA; Cisterna Cáncer R; García Cebrián F
    Arch Bronconeumol; 2005 Apr; 41(4):189-96. PubMed ID: 15826528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.